Levyx and Vexata Set New Bar for Performance Benchmarks for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
33
Levyx and Vexata Set New Bar for Performance Benchmarks for Large-Scale Financial Trading Applications

IRVINE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Levyx Inc., whose high-performance, ultra-low latency data processing software dramatically reduces Big Data infrastructure costs, in conjunction with Vexata, the leader in high-performance NVMe Flash storage systems, revealed record-shattering independent testing results performed by the Securities Technology Analysis Center (STAC ® ) using the STAC-A3™ benchmarking suite. In one benchmark, the Levyx-Vexata solution achieved 35% more trading simulations per second while using 70% fewer servers*. Levyx and Vexata estimate that the cost of the new solution is just a third of the previous record holder, providing nearly a 300% improvement in price/performance. Levyx had previously set the STAC-A3 mark in 2017. Working with Vexata is an important next step since it demonstrates the performance-enhancing potential of Levyx’s software in highly-parallelized NVMe flash-based architectures. The underlying NVMe storage layer delivered by Vexata matches Levyx’s persistent dataframe layer resulting in a solution that serves as an ideal alternative to memory for hosting live datasets, all in a bulletproof enterprise-grade system. As NVMe storage systems become more prevalent in Big Data-class environments, Levyx products play a key role as an enabling software layer for all hardware providers capitalizing on the transition to data centric computing in modern datacenters.

Zahid Hussain, CEO of Vexata, said: “When microseconds matter, Levyx’s Xenon accelerated computing platform running on Vexata’s accelerated enterprise storage offers a compelling, high-performance solution for backtesting and risk analytics.”

Peter Lankford, Director of STAC, added: “Across the trading and investment industry, firms are working to turn large amounts of data into profitable strategies through techniques like machine learning. Backtesting potential strategies is a crucial step in that process, and it requires technology that can handle big data at high speed. Quant funds and banks in the STAC Benchmark Council specified the benchmarks in STAC-A3 as an independent way to measure the ability of software and hardware innovations to accelerate backtesting workloads. The fact that Vexata and Levyx submitted a solution for rigorous STAC-A3 testing shows that they are focused on helping financial firms get new strategies to market more quickly.”

"We are very pleased to work with a partner like Vexata to reach another performance milestone," said Reza Sadri, CEO of Levyx. "Introducing our persistent DataFrame layer in a system as fast as the Vexata VX-100F demonstrates the expanding opportunities for Flash-based arrays in large-scale, highly-transactional use cases in areas like financial benchmarking. Now, these high throughput, low latency systems can be used in use cases beyond storage by introducing an enterprise-grade alternative for memory resident data -- however, an alternative that is much denser, simpler to implement, and has all enterprise capabilities of storage networking such as sharability, scalability, and high availibility."

The new benchmark records were set with Apache Spark accelerated by Levyx Xenon™ and utilizing six Intel Xeon SP-based servers connected via Fibre Channel to the Vexata VX-100F Scalable NVMe Flash Array in a combined solution.

Vexata Scalable NVMe Flash Arrays enable the highest performance at market-leading economics for database and analytics workloads, as well as for emerging artificial intelligence (AI) and machine learning (ML) use cases. Mimicking the approach used by AI and ML frameworks that achieve acceleration using GPUs, the Vexata arrays feature hardware accelerators that enable nearly 20x higher performance than existing all-flash arrays that use traditional storage architectures.

The Levyx Xenon platform is widely used in the financial services industry for accelerating backtesting and risk-management workloads. Levyx’s risk analytics acceleration platform significantly speeds up the validation of trading algorithms and strategies leading to lower deployment costs and execution times, while improving time to revenues.

* Performance in the STAC-A3.β1.SWEEP.SPEED2.BEST benchmark compared to the previous record holder (SUT ID:  HPAT171029).

About Levyx Inc. Levyx’s software solutions fundamentally disrupt the economics of Big-Data applications, bringing the benefits of high-speed Big-Data processing to the masses. No longer reserved for the largest enterprises, Levyx technology can process hundreds of millions of queries per second on commodity servers on a few nodes, making Big-Data processing much more accessible to organizations of all sizes. More information is available at  www.levyx.com .

The STAC Report™ may be downloaded for free by going to: www.STACresearch.com/LEVX180608

For additional STAC content related to Levyx, please go to: www.STACresearch.com/levyx

Levyx, the Levyx logo, and Xenon are trademarks of Levyx Inc. STAC and all STAC names are trademarks or registered trademarks of the Securities Technology Analysis Center, LLC.  All other trademarks or brand names referred to in this press release are the property of their respective owners.

Levyx Press Contact: Luis Morales (949) 466-2738 morales@levyx.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 16

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 37

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading

Top 5 Most Recently Viewed Articles

Neurotrope, Inc. Achieves New Milestone with Stock Surge

Updated Category News Views 147

Neurotrope, Inc. Reaches New Stock Milestone Neurotrope, Inc. (NASDAQ: NTRP) has recently achieved a significant milestone in the stock market, soaring to a 52-week high with its price reaching $7.00. This impressive climb indicates a remarkable 124.95% increase over the past year, showcasing strong investor interest and confidence in the company's future prospects. The...

Continue Reading
Lil Nas X's Legal Challenges and Public Struggles Unfold

Updated Category News Views 284

Lil Nas X Pleads Not Guilty to Serious Charges Grammy-winning musician Lil Nas X has recently made headlines for pleading not guilty to multiple felony charges stemming from an incident involving police officers. This situation arose when he was found walking unclothed on the streets of Los Angeles. Understanding the Legal Battle Ahead The rapper, known legally as Montero...

Continue Reading
Exyte's Strategic Acquisition of TTP Group Enhanced Operations

Updated Category News Views 51

Exyte Acquires TTP Group to Strengthen Engineering Expertise Exyte, a leader in high-tech facility engineering, has officially completed the acquisition of TTP Group, enhancing its operations and expertise especially in the biopharma and life sciences sectors. This acquisition marks a significant milestone for Exyte as it melds TTP's capabilities with its own, aiming to...

Continue Reading
Unveiling Health Innovations: Zepp Health at CES 2024 Events

Updated Category News Views 372

Zepp Health Showcases Innovative Technologies at CES Zepp Health Corporation (NYSE: ZEPP), a leader in health technology and smart wearables, is excited to announce its participation in significant media events like Pepcom and ShowStoppers at CES. These occasions will showcase Zepp Health's latest advancements in smart wearables and health technologies, aimed at...

Continue Reading
Meridian Locks $186M Loan for NJ Condo Project

Updated Category News Views 163

New Jersey's Coastline Gets a $186 Million Facelift Here's a move that'll shake the Jersey Shore awake: Meridian Capital Group's just put their money where the sand is with a massive $186 million scoop for a new high-end condominium project in Asbury Park. You couldn't make up a better setting—a beachfront spot ripe for some high-end living. But let's not get too...

Continue Reading